EXERCISING TOGETHER for Couples Coping With Cancer

NCT03630354 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 496

Last updated 2025-07-01

Study results available
· View outcomes & findings →

Summary

The Exercising Together trial is a single-blind, parallel group, randomized controlled trial comparing 3 arms: Arm 1 (experimental): Exercising Together where couples perform partnered exercise in a supervised, group setting versus two comparator conditions where survivors and partners perform exercise routines separately in either a supervised group setting (Arm 2) or unsupervised at home (Arm 3). All three arms will train for a 6-month period and then be followed 6 months later. Data will be collected at baseline, 3, 6 and 12 months.

Conditions

  • Anatomic Stage I Breast Cancer AJCC v8
  • Anatomic Stage II Breast Cancer AJCC v8
  • Anatomic Stage III Breast Cancer AJCC v8
  • Breast Carcinoma
  • Colorectal Carcinoma
  • Malignant Solid Neoplasm
  • Prostate Carcinoma
  • Stage I Colorectal Cancer AJCC v8
  • Stage I Prostate Cancer AJCC v8
  • Stage II Colorectal Cancer AJCC v8
  • Stage II Prostate Cancer AJCC v8
  • Stage III Colorectal Cancer AJCC v8
  • Stage III Prostate Cancer AJCC v8

Interventions

BEHAVIORAL

Exercise Intervention (supervised)

Complete supervised exercise

BEHAVIORAL

Exercise Intervention (unsupervised)

Complete unsupervised exercise

OTHER

Informational Intervention

Receive instructional DVD

OTHER

Questionnaire Administration

Ancillary studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • Oregon Health and Science University

    collaborator OTHER
  • OHSU Knight Cancer Institute

    lead OTHER

Principal Investigators

  • Kerri Winters-Stone · OHSU Knight Cancer Institute

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-18
Primary Completion
2024-01-01
Completion
2024-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03630354 on ClinicalTrials.gov